An executive comfortably using the BPAro 24-hour Ambulatory Blood pressure monitoring system while working in the board room. Credit: CNW Group / CardiAI Inc.

Biotechnology company CardiAI has announced the worldwide introduction and distribution of BPAro, a new 24-hour Ambulatory Blood Pressure Monitoring (ABPM) system.

The compact, portable, self-monitoring blood pressure device includes Bluetooth for the wireless collection of data, which is uploaded to a secure cloud database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It is clinically validated for accuracy and has already received approvals from the US Food and Drug Administration (FDA) and Health Canada.

The German-manufactured device can serve as a diagnostic foundation by constantly monitoring human blood pressure and automatically recording patient blood pressure at regular intervals for up to 30 hours.

It has been designed and tested to be user-friendly and has simple instructions for patients and doctors.

The new ABPM device can collect blood pressure measurements at 30-minute intervals for up to seven days.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

CardiAI founder and CEO Dr Anmol Kapoor said: “BPAro is the first to release among a number of point-of-care devices that will bridge the gap between a patient’s everyday life and the doctor’s office to aid in better patient treatment and preventative healthcare solutions.”

“High blood pressure can be a serious condition that could lead to heart attacks, strokes, kidney failure and loss of vision.

“Accurate and long-term blood pressure metrics aid in patient diagnosis and treatment. BPAro removes uncertainty and puts precision medicine in your hands.”

The device wirelessly uploads data to the BPAro app, and the data generated is used to create a blood pressure profile for each patient in a personal cloud account.

By synchronising the patient and physician results in real-time, the device provides blood pressure monitoring for evidence-based healthcare records.